GBIW.OB Insider Trading Activity and SEC Form 4 Filings
GBIW.OB insider trading summary
No open-market insider purchases or sales of Genesis Bioventures Inc (GBIW.OB) have been reported on SEC Form 4 in the past 12 months.
Latest GBIW.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 21, 2007 | FG2 Advisors, LLC | 10% Owner | Buy | $3K (50,000 @ $0.05) |
| Sep 21, 2007 | Firebird Global Master Fund II, Ltd. | 10% Owner | Buy | $3K (50,000 @ $0.05) |
| Sep 21, 2007 | James Passin | 10% Owner | Buy | $3K (50,000 @ $0.05) |
| Sep 21, 2007 | Harvey Sawikin | 10% Owner | Buy | $3K (50,000 @ $0.05) |
| Feb 15, 2006 | E Greg McCartney | CEO | Buy | $1014.38B (2,213,281 @ $458315.00) |
| Feb 13, 2006 | Larry T Pasemko | Executive Vice President | Buy | $844.08B (2,023,374 @ $417166.00) |
| Feb 13, 2006 | T J Louis McKinney | CFO | Buy | $348.10B (1,299,186 @ $267934.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.